November 02, 2026 | 12pm EST: Build Patient-Site Trust to Improve Clinical Trial Retention

X

Researchers Identify Multi-Action Drug Candidate For Type 2 Diabetes And Bone Disease

Posted on: in News | Life Science News | Pharma News
By:

Related Vitals

Sanofi Opens $925M Toronto Vaccine Facility
The investment expands Sanofi’s Toronto manufacturing footprint and will strengthen Canada’s domestic flu vaccine and pandemic-response capacity.
News

Northway Biotech Opens $70.8M Cell Therapy CDMO Facility in Vilnius, Lithuania
Vilnius, Lithuania, is home to Northway Biotech’s new cell therapy and personalized medicine manufacturing center.
News

From Oxfordshire to Wales: Where UK Life Sciences Investment Is Going in 2026
Cambridge is one of several UK life sciences hubs attracting new investment in R&D, manufacturing and biopharma infrastructure.
News

Bristol Myers Squibb Invests $2.3B in Houston Drug Manufacturing
Bristol Myers Squibb Houston manufacturing
News

Lilly and Resilience Invest $750M to Expand Medicine Production in Ohio
Lilly Resilience Ohio manufacturing investment
Pharmaville: Powering Life Sciences Location Strategy and FDI

Related Webinars

December 02, 2026

Reduce Patient Recruitment Delays With EHR and Applied AI
Hero - Desktop
December 04, 2026

Improve Pharmaceutical Packaging Throughput With Serialization
Hero - Desktop
December 10, 2026

Improve Inflammatory Skin Disease Trials Beyond Immune Targets
Hero - Desktop
December 11, 2026

Improve Pharmacovigilance Compliance in In-Trial Patient Interviews
Hero - Desktop
December 14, 2026

Strengthen Preclinical Evidence for New Therapies Using NHP Research
Hero - Desktop